ReWalk Robotics Ltd. (NASDAQ: LFWD) reported Q4 EPS of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $6.88 million versus the consensus estimate of $7.23 million.

GUIDANCE:

ReWalk Robotics Ltd. sees FY2024 revenue of $28-32 million, versus the consensus of $33.1 million. non-GAAP gross margin to expand to the high 40%s, non-GAAP operating expenses to decline from the fourth quarter 2023 run rate level as a result of the integration savings, and non-GAAP operating loss to decline to the low double-digit millions.

For the first quarter, which is typically the lowest volume quarter of each year, Lifeward sees revenue of between $5.0 to $5.5 million, versus the consensus of $7.6 million, the Company expects revenue will increase in subsequent quarters consistent with historical patterns and due to the phasing in of Medicare revenue and the contribution of the AlterG new product introduction expected to start mid-year. The expectations for the first quarter of 2024 do not include Medicare revenue.

For earnings history and earnings-related data on ReWalk Robotics Ltd. (LFWD) click here.